NCT03794921

Brief Summary

Persons with COPD have significant functional disability but cannot access rehabilitative treatment at hospital-based conventional pulmonary rehabilitation (PR) programs. This project will determine whether an Internet-mediated, pedometer-based walking program can increase physical activity in persons with COPD who qualify for but cannot access PR, compared to usual care. This proposal has high potential to deliver an immediate solution to a pressing clinical need. The proposed research addresses Rehabilitation R\&D Service's current priority area of improving disabled Veterans' health-related quality of life by reducing disease burden and maximizing functional recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 7, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

September 17, 2019

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

April 2, 2026

Completed
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

5 years

First QC Date

December 18, 2018

Results QC Date

January 30, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

Pulmonary RehabilitationTechnology-MediatedWeb-Based InterventionPhysical Activity

Outcome Measures

Primary Outcomes (1)

  • Physical Activity Measured as Change in Average Daily Step Count

    Daily Step Count was directly measured with a wearable monitoring device. Change in daily step count at 12 weeks compared to baseline from the adjusted mixed model.

    12 weeks compared to baseline

Secondary Outcomes (8)

  • Exercise Self-Regulatory Efficacy Measured as Change Score

    12 weeks compared to baseline

  • Disease Specific Health-Related Quality of Life Measured as Change Score

    12 weeks compared to baseline

  • Shortness of Breath Rating as Perceived by the Participant Measured as Change Score

    12 weeks compared to baseline

  • Depression Self-reported on Questionnaire Measured as Change Score

    12 weeks compared to baseline

  • CHAMPS Physical Activity Questionnaire Measured as Change Score

    12 weeks compared to baseline

  • +3 more secondary outcomes

Other Outcomes (7)

  • Health Utilities Measured as Change Score

    12 weeks compared to baseline

  • Number of Participants Who Plan to Enroll in Conventional Pulmonary Rehabilitation After Participating in the Research Study

    12 weeks

  • COPD Knowledge Measured as Change Score

    12 weeks compared to baseline

  • +4 more other outcomes

Study Arms (2)

Usual Care

NO INTERVENTION

Patients referred to conventional PR or eligible for PR but declined or cannot access. Using a standardized script at the randomization phone call, study staff will deliver verbal instructions to slowly and steadily increase one's walking and exercise each week. Participants will be asked to perform exercise of moderate intensity for at least 30 minutes on most days of the week, defined as a dyspnea level of 4-5 on the Borg scale and taking 1-2 minutes to recover. Use of the Borg rating scale for dyspnea will be reviewed with each participant. Exercise is defined as planned PA, outside of activities performed as part of one's daily routine. Exercise can be walking in the community or using exercise equipment at a local gym. Adapted written materials reinforce the verbal instructions. Participants will receive this 45-page spiral-bound book with information about aerobic and strength training exercises.

Every Step Counts Intervention

EXPERIMENTAL

Patients referred to conventional PR or eligible for PR but declined or cannot access. After randomization to ESC, participants will be mailed detailed instructions about the website. They will be asked to wear the lightweight, unobtrusive pedometer every day, except while asleep or showering/bathing, during the 12-week intervention period. Subjects will be instructed to upload their date and time-stamped step-count data to the study website at least weekly. Each week, the study computer will run the goal calculation algorithm and provide each participant with his/her daily step-count goal for the week. The week's step-count goal will be displayed on each subject's personal study web page. Participants will be instructed to exercise and reach their individualized step-count goals with walking of moderate intensity for at least 30 minutes on most days of the week, defined as a dyspnea level of 4-5 on the Borg scale and taking 1-2 minutes to recover.

Other: Every Step Counts

Interventions

Pedometer coupled to a website that provides step-count goals, feedback, education, motivation, and social support.

Every Step Counts Intervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female subjects, greater than or equal to 40 years of age
  • Clinical diagnosis of COPD defined as: 1 of the following as testing-based evidence of COPD (any documented FEV1/FVC \< 0.70, chest CT evidence of emphysema) AND at least 2 of the following as clinical evidence of COPD (≥ 10 pack-year cigarette smoking history, taking an antimuscarinic inhaler such as ipratropium or tiotropium, diagnosis of COPD written in a provider's note or on problem list)
  • Have declined participation in a conventional pulmonary rehabilitation program
  • Medical clearance from healthcare provider to participate in an exercise program
  • Have Internet connection and Bluetooth capability, and access to video platform Cisco Webex#
  • Answer yes to "Does your shortness of breath interfere with your functioning?"
  • Answer no to "Are you interested in joining PR now? If they answer yes, they will be ineligible and the PI will place a consult to PR for further evaluation
  • Competent to provide informed consent
  • Willingness to make return visits and be available by telephone for duration of study

You may not qualify if:

  • COPD exacerbation in the previous 1 month
  • Prescribed supplemental oxygen for activity+
  • Inability to ambulate with or without assistance
  • Use of assistive device for walking such as cane or walker\*
  • Inability to complete questionnaires
  • Inability to collect at least 7 of 10 days of baseline step counts
  • Participation in a pulmonary rehabilitation program at time of screening or within the previous 3 months
  • Participation in another exercise-related research study at time of screening
  • Plans to participate in an exercise-related research study in the next 3 months
  • Average baseline step counts of greater than or equal to 10,000 steps per week
  • For those who wish to participate virtually.
  • If participant has an in-person visit, oxygen will be assessed during the 6MWT to determine if subject's oxygen is stable during activity. If a participant has an in-person visit and oxygen is documented during the 6MWT and stays above 85%, he/she will be eligible to participate.
  • If a participant uses an assistive walking device but we have previously shown that the Fitbit pedometer is accurate in him/her (before the study was transitioned to virtual) he/she will be allowed to participate in the study. If a participant has an in-person visit and Fitbit accuracy is documented during use of the assistive device he/she will be eligible to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Boston, Massachusetts, 02130-4817, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Limitations and Caveats

First, changes such as how visits were conducted were made to the study protocol after the trial was underway due to the COVID-19 pandemic. Second, walking intensity was not objectively measured. Third, the lack of racial and ethnic diversity and paucity of women limits generalizability of results.

Results Point of Contact

Title
Marilyn Moy, MD
Organization
VA Boston Healthcare System

Study Officials

  • Marilyn L. Moy, MD

    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Study staff communicating randomization assignments to subjects will be different from study staff conducting follow-up outcome assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: As the primary aim, the investigators propose a RCT to study the efficacy of a web-based, pedometer-mediated physical activity intervention to increase physical activity in persons with COPD who would benefit from but cannot access conventional pulmonary rehabilitation, compared to usual care. The investigators anticipate that 120 subjects will be randomized 1:1 to either the intervention or usual care.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2018

First Posted

January 7, 2019

Study Start

September 17, 2019

Primary Completion

September 10, 2024

Study Completion

September 10, 2024

Last Updated

April 2, 2026

Results First Posted

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Datasets meeting VA standards for disclosure to the public will be made available within 1 year of publication. * A local privacy officer will certify that a dataset contains no Protected Health Information (PHI), Personally Identifiable Information (PII), or VA Sensitive Information prior to release outside VA. * Final data sets will be maintained locally on a secure server or comparable data storage appliance inside the VA network until enterprise-level resources become available for long-term storage and access. The PI will create de-identified, study-specific datasets. Investigators requesting a copy of a dataset will sign a Letter of Agreement or a Data Use Agreement. A local privacy officer will certify that a dataset contains no PHI, PII, or VA Sensitive Information prior to release outside VA.

Locations